David Twesigomwe

Featured in: Favicon

nature.com Favicon

futuremedicine.com Favicon

biorxiv.org Favicon

onlinelibrary.wiley.com

Articles

Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations

Dec 4, 2023 | ascpt.onlinelibrary.wiley.com | David Twesigomwe |Britt I Drögemöller |Rady Faculty |Max Rady College

WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC? ☑ CYP2B6 and CYP2A6 genetic variation contributes to clinically relevant differences in response to antiretrovirals, nicotine, and bupropion (among other drugs) across individuals and populations. CYP2B6 and CYP2A6 are therefore important genes in clinical pharmacogenetic implementation initiatives globally.
Characterization of CYP2C19 pharmacogenetic variation in African populations and comparison with other global populations

Nov 6, 2023 | futuremedicine.com | Byrska-Bishop M |Evani US |Ross P Booyse |David Twesigomwe

FiguresReferencesRelatedDetails Supplemental MaterialsMetricsHistoryReceived 24 August 2023 Accepted 12 October 2023 Published online 6 November 2023 Information© 2023 Future Medicine LtdSupplementary dataTo view the supplementary data that accompany this paper please visit the journal website at: www.futuremedicine.com/doi/suppl/10.2217/pgs-2023-0166Author contributionsRP Booyse, D Twesigomwe and S Hazelhurst designed the study.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →